The scientific community has already claimed that high levels of blood sugar and cholesterol in people over 35 may be linked to Alzheimer's disease in the future. However, according to a study published in the journal Alzheimer's & Dementia, "good" cholesterol (HDL) may help protect against the disease. Come check out more about this research.
Read more: Check out habits that exercise the brain and prevent diseases like Alzheimer's
see more
Secret of youth? Researchers reveal how to reverse…
The "powers" of porridge: check out the benefits of oats in…
First, understand what the Alzheimer's condition is
Alzheimer's disease causes problems with memory, thinking and behavior. This disease is the most common form of dementia and is a general term used to describe conditions that occur when the brain no longer functions optimally.
HDL cholesterol
HDL cholesterol is well known for its role in acting directly in our body's fat elimination process. Thus, it directs molecules from inside the vessels to the liver, where they are properly metabolized and eliminated.
He is also responsible for preventing heart disease and has anticoagulant, anti-inflammatory and antioxidant properties. Some foods rich in this cholesterol, such as avocados, chestnuts, peanuts and sardines can raise HDL levels in the body. In addition to regular physical activity, it can also help you to increase these levels.
Relationship between disease and HDL
To conduct the study, researchers identified, counted, and measured plasma HDL levels in 180 healthy adults with an average age of 76 years. According to the article, the more particles there are, the better the person's cognitive function will perform.
The group also found that this association was stronger in individuals without cognitive impairment, implying a role for HDL cholesterol in preventing Alzheimer's disease.
The study's theory is that the particles may reduce the risk of disease by altering the composition of neuronal membranes and affecting vascular and sensory functions. The study therefore concluded that plasma HDL levels can be used as biomarkers to guide future clinical trials in Alzheimer's prevention.
In addition, it also has the potential to aid in the development of new therapeutic agents. As a result, research continues and researchers hope to discover new approaches to treating patients with "good" (HDL) cholesterol.